Infectious Disease(BK22995)
Increase:2
Decrease:16
Total:17
Total 17 records
| code | marketCap | change | rps50 | rps120 | rps250 | industry | sectors |
|---|---|---|---|---|---|---|---|
| 228.39B | -0.72% | 92 | 86 | 77 | Medical Devices | Infectious Disease;Mpox (monkeypox) | |
AstraZeneca AZN | 225.15B | -1.22% | 87 | 53 | 67 | Drug Manufacturers - General | Infectious Disease |
BioNTech BNTX | 21.67B | -0.85% | 31 | 27 | 52 | Biotechnology | Infectious Disease |
| 18.79B | +0.05% | 89 | 81 | 83 | Diagnostics & Research | CRO;Infectious Disease;Mpox (monkeypox) | |
Gilead Sciences GILD | 138.73B | -0.69% | 95 | 92 | 93 | Drug Manufacturers - General | CAR-T Therapy;Cancer Research;Infectious Disease;Mpox (monkeypox) |
| 78.16B | -2.25% | 91 | 62 | 49 | Drug Manufacturers - General | CAR-T Therapy;Infectious Disease | |
| 369.31B | -7.59% | 80 | 57 | 55 | Drug Manufacturers - General | CAR-T Therapy;Infectious Disease | |
| 19.47B | -0.04% | 64 | 77 | 65 | Diagnostics & Research | CRO;Infectious Disease | |
Merck & Co MRK | 220.07B | -2.94% | 42 | 34 | 31 | Drug Manufacturers - General | ESG Investing;Cancer Research;Infectious Disease |
Moderna MRNA | 10.50B | -4.20% | 32 | 9 | 9 | Biotechnology | Infectious Disease |
Pfizer PFE | 139.18B | -3.16% | 56 | 44 | 50 | Drug Manufacturers - General | CAR-T Therapy;Cancer Research;Weight Loss Drugs;Infectious Disease |
| 10.98B | -0.23% | 45 | 39 | 47 | Drug Manufacturers - Specialty & Generic | Cannabis & Hemp;Infectious Disease | |
| 67.45B | -2.72% | 45 | 18 | 28 | Biotechnology | ARK Portfolio;Infectious Disease | |
Sanofi SNY | 137.28B | -2.02% | 84 | 59 | 74 | Drug Manufacturers - General | Infectious Disease |
| 45.74B | +0.20% | 91 | 70 | 65 | Drug Manufacturers - Specialty & Generic | Infectious Disease | |
| 17.34B | -0.52% | 20 | 43 | 66 | Drug Manufacturers - Specialty & Generic | ARK Portfolio;Cannabis & Hemp;Infectious Disease | |
| 182.21B | -2.94% | 39 | 35 | 42 | Diagnostics & Research | Infectious Disease |